Last updated on February 2018

RIXUBIS Drug Use-Result Survey (Japan)


Brief description of study

The purpose of this survey is to understand the following items observed in the actual clinical use of RIXUBIS.

  1. Unexpected adverse drug reactions
  2. Occurrence of adverse drug reactions in the actual clinical use
  3. Factors that may affect safety and effectiveness
  4. Occurrence of Factor IX (FIX) inhibitor development in patients with coagulation FIX deficiency
  5. Safety and effectiveness for hemophilia B patients who received routine prophylactic therapy, on-demand therapy and perioperative therapy

Clinical Study Identifier: NCT02937831

Contact Investigators or Research Sites near you

Start Over

Claudia Schwarz, PhD

Seki-shi, Japan
Seki-shi, Japan
  Connect »

Claudia Schwarz, PhD

Maebashi-shi, Japan
Maebashi-shi, Japan
  Connect »

Claudia Schwarz, PhD

Osaka-shi, Japan
Osaka-shi, Japan
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.